|
FAM114A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.950800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.805600E-02 |
| Normal-vs-Stage2 |
5.144400E-01 |
| Normal-vs-Stage3 |
4.598200E-01 |
| Normal-vs-Stage4 |
7.133000E-01 |
| Stage1-vs-Stage2 |
6.699400E-01 |
| Stage1-vs-Stage3 |
1.058820E-01 |
| Stage1-vs-Stage4 |
4.129800E-01 |
| Stage2-vs-Stage3 |
3.269600E-01 |
| Stage2-vs-Stage4 |
5.456000E-01 |
| Stage3-vs-Stage4 |
9.955000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.911400E-01 |
| Normal-vs-AfricanAmerican |
5.110100E-02 |
| Normal-vs-Asian |
2.470100E-02 |
| Caucasian-vs-AfricanAmerican |
1.090450E-01 |
| Caucasian-vs-Asian |
5.786100E-02 |
| AfricanAmerican-vs-Asian |
4.674000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.316600E-03 |
| Normal-vs-Female |
2.030300E-02 |
| Male-vs-Female |
1.790140E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.351400E-01 |
| Normal-vs-Extreme_Weight |
4.315300E-03 |
| Normal-vs-Obese |
4.825800E-01 |
| Normal-vs-Extreme_Obese |
6.356700E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.314600E-01 |
| Normal_Weight-vs-Obese |
1.922410E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.091770E-01 |
| Extreme_Weight-vs-Obese |
9.604400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.512600E-01 |
| Obese-vs-Extreme_Obese |
4.283500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.668200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.927600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.982200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.482640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.286400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.344990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.345380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.223600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.131810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.746000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.317550E-02 |
| Normal-VS-Type2 PRCC |
2.969600E-01 |
| Normal-VS-KIRP CIMP |
4.980300E-02 |
| Normal-VS-Unclassified PRCC |
1.336200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.241000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.601500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.226060E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.531600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.705700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.600400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.039000E-01 |
| Normal-vs-N1 |
4.150800E-01 |
| Normal-vs-N2 |
3.855200E-01 |
| N0-vs-N1 |
1.626370E-01 |
| N0-vs-N2 |
3.353400E-01 |
| N1-vs-N2 |
2.335400E-01 |
|
|
